Is Phosphodiesterase inhibition a new mechanism of antidepressant action?
Authors:
- 1 November 1988
- journal article
- research article
- Published by Springer Nature in European Archives of Psychiatry and Clinical Neuroscience
- Vol. 238 (1) , 2-6
Abstract
Unlike conventional antidepressants, rolipram (a new approach in the treatment of depression) stimulates both the presynaptic and the postsynaptic component of monoaminergic transmission. Several double blind trials are under way to assess the clinical efficacy and safety of this compound. The present study was a randomized, 4-week interindividual double blind double-dummy comparison with desipramine in inpatients with major (DSM-III) and/or endogenous (ICD-9) depressions. After a minimum washout period of three days the patients received either 0.50 mg rolipram or 25 mg desipramine orally t.i.d. for the first three days, then 0.75 mg rolipram or 50 mg desipramine t.i.d. until day 28. Rating tests were based principally on the AMDP-system and the HAMD scale. The study showed no differences between the two drugs as regards the efficacy, but a definite trend in favour of rolipram as regards the side effects and, in particular, anticholinergic effects.Keywords
This publication has 7 references indexed in Scilit:
- Absence of Anticholinergic Activity of Rolipram, an Antidepressant with a Novel Mechanism of Action, in three Different Animal Models in VivoPharmacopsychiatry, 1988
- Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptorsNeuropharmacology, 1986
- Effects of rolipram, a novel antidepressant, on monoamine metabolism in rat brainJournal of Neural Transmission, 1985
- Results of a Phase II Study of the Antidepressant Effect of RolipramPharmacopsychiatry, 1984
- Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitorsNeuropharmacology, 1983
- Brain cyclic AMP and memory in micePharmacology Biochemistry and Behavior, 1982
- THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCEAmerican Journal of Psychiatry, 1965